Hiroyuki Nishiyama

Preoperative prognostic model for localized and locally advanced renal cell carcinoma: Michinoku Japan Urological Cancer Study Group

T. Habuchi, N. Tsuchiya, C. Ohyama, 2023, International Journal of Clinical Oncology.

Glycoprotein nonmetastatic melanoma protein B impacts the malignant potential of bladder cancer cells through its hem‐immunoreceptor tyrosine‐based activation motif

Y. Nagumo, Yukari Okita, T. Kimura, 2024, Pathology international.

TAS0313 plus Pembrolizumab for Post-Chemotherapy Immune Checkpoint Inhibitor—Naïve Locally Advanced or Metastatic Urothelial Carcinoma

J. Yonese, N. Matsubara, S. Fukasawa, 2023, Molecular cancer therapeutics.

Efficacy and safety of axitinib for metastatic renal cell carcinoma: Real-world data on patients with renal impairment.

H. Shiina, S. Anai, A. Yokomizo, 2023, Urologic oncology.

Association of increased age with decreased response to intravesical instillation of Bacille Calmette-Guérin in patients with high-risk non-muscle invasive bladder cancer: Retrospective multi-institute results from the Japanese Urological Oncology Research Group JUOG-UC-1901-BCG.

H. Nishiyama, T. Habuchi, J. Inokuchi, 2022, Urology.

The efficacy of molecular targeted therapy and nivolumab therapy for metastatic non‐clear cell renal cell carcinoma: A retrospective analysis using the Michinoku Japan urological cancer study group database

T. Habuchi, N. Tsuchiya, C. Ohyama, 2023, Cancer medicine.